In vitro cultures of human HNSCC cells as well as mouse xenograft models indicate that PI3K signaling is linked to cancer radiation resistance, and PI3K inhibition has shown promise in potentiating the cytotoxic and anti-mitotic effects of radiotherapy [8,9]. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.